000 | 01049 a2200301 4500 | ||
---|---|---|---|
005 | 20250511181145.0 | ||
264 | 0 | _c19920701 | |
008 | 199207s 0 0 eng d | ||
022 | _a0315-162X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKuipers, E J | |
245 | 0 | 0 |
_aSulfasalazine induced agranulocytosis treated with granulocyte-macrophage colony stimulating factor. _h[electronic resource] |
260 |
_bThe Journal of rheumatology _cApr 1992 |
||
300 |
_a621-2 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article; Review | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAgranulocytosis _xchemically induced |
650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
650 | 0 | 4 |
_aBone Marrow _xpathology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGranulocyte-Macrophage Colony-Stimulating Factor _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aSulfasalazine _xadverse effects |
700 | 1 | _aVellenga, E | |
700 | 1 | _ade Wolf, J T | |
700 | 1 | _aHazenberg, B P | |
773 | 0 |
_tThe Journal of rheumatology _gvol. 19 _gno. 4 _gp. 621-2 |
|
999 |
_c1357139 _d1357139 |